Y Liu, L An, R Huang, J Xiong, H Yang, X Wang… - Biomarker …, 2022 - Springer
Chimeric antigen receptor T (CAR-T) cell therapy has significantly improved the life
expectancy for patients with refractory or relapse B cell lymphoma. As for B cell acute …